| Original language | English (US) |
|---|---|
| Pages (from-to) | 463-465 |
| Number of pages | 3 |
| Journal | Parkinsonism and Related Disorders |
| Volume | 19 |
| Issue number | 4 |
| DOIs | |
| State | Published - Apr 2013 |
All Science Journal Classification (ASJC) codes
- Neurology
- Geriatrics and Gerontology
- Clinical Neurology
Access to Document
Other files and links
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease. / Armstrong, Melissa J.; Duff-Canning, Sarah; Tang-Wai, David F.; Fox, Susan; Zadikoff, Cindy; Kennedy, Nancy; Gill, David; Eslinger, Paul J.; Mapstone, Mark; Chou, Kelvin L.; Persad, Carol; Litvan, Irene; Mast, Benjamin T.; Marras, Connie.
In: Parkinsonism and Related Disorders, Vol. 19, No. 4, 04.2013, p. 463-465.Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - The meaning of a "hippo" response on the Montreal Cognitive Assessment in Parkinson's disease
AU - Armstrong, Melissa J.
AU - Duff-Canning, Sarah
AU - Tang-Wai, David F.
AU - Fox, Susan
AU - Zadikoff, Cindy
AU - Kennedy, Nancy
AU - Gill, David
AU - Eslinger, Paul J.
AU - Mapstone, Mark
AU - Chou, Kelvin L.
AU - Persad, Carol
AU - Litvan, Irene
AU - Mast, Benjamin T.
AU - Marras, Connie
N1 - Funding Information: This study was supported by a grant from the Michael J. Fox Foundation . Melissa J. Armstrong: Support as an Edmond J. Safra fellow at Toronto Western Hospital while working on this project. Current research support from Abbott . Sarah Duff-Canning: Research support from Michael J Fox Foundation, National Parkinson Foundation , and Canadian Institutes of Health Research . Susan Fox: Research support from the Parkinson Society Canada, Michael J. Fox Foundation, and NIH. Consultancy from Teva, Novartis, Santhera, Merz, Merck Serono. Cindy Zadikoff: Research support from Parkinson Alliance . Consultancy and honoraria from Teva, GSK, Merz, Allergan, Ipsen, and Abbott. Paul J. Eslinger: Research support from National Institute of Health ( NS060722 , ES019672 , AG027771 ) and the Pennsylvania Department of Health . Mark Mapstone: Research support from the National Institute of Health, Michael J. Fox Foundation, Neurologix, Inc. , and Advanced Neuromodulation System, Inc . Honoraria from the Michael J. Fox Foundation. Kelvin L. Chou: Research support from the National Institute of Health ( NS44504-08 ) and participates as a site-PI in clinical trials sponsored by the HSG (PHAROS, 2CARE, and CREST-HD). Royalties from UpToDate. Speaking honoraria from Allergan. Consulting honoraria for Medtronic and Merz Pharmaceuticals. Carol Persad: Research support from National Institute of Health ( P01 NS015655-26A1 , MCASTL RFP2010-04 ). Irene Litvan: Research support from National Institute of Health ( R01 PAS-03-092 NIA), National Parkinson Foundation, Parkinson Support Center of Kentuckiana, CurePSP, Noscira, Allon Therapeutics, and Parkinson Study Group. Consultant for Teva, Novartis, Santhera, Merz, Merck Serono, and Bristol-Myers Squibb. Connie Marras: Research support from the Canadian Institutes of Health Research, Michael J. Fox Foundation, National Parkinson Foundation, Merck Serono and Allon Therapeutics. David F. Tang-Wai, Nancy Kennedy, David Gill, and Benjamin T. Mast report no disclosures.
PY - 2013/4
Y1 - 2013/4
UR - http://www.scopus.com/inward/record.url?scp=84875248110&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84875248110&partnerID=8YFLogxK
U2 - 10.1016/j.parkreldis.2012.09.005
DO - 10.1016/j.parkreldis.2012.09.005
M3 - Letter
C2 - 23036511
AN - SCOPUS:84875248110
VL - 19
SP - 463
EP - 465
JO - Parkinsonism and Related Disorders
JF - Parkinsonism and Related Disorders
SN - 1353-8020
IS - 4
ER -